Olynth HA 0,5 mg/ml sprej za nos, otopina
| Name | Olynth HA 0,5 mg/ml sprej za nos, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-452462150 |
| Active Substance | ksilometazolinklorid |
| Composition | jedan ml spreja za nos, otopine sadrži 0,5 mg ksilometazolinklorida; jedan potisak (70 µl) sadrži 0,035 mg ksilometazolinklorida |
| Pharmaceutical Form | sprej za nos, otopina |
| Manufacturer | Famar Health Care Services Madrid S.A.U., Alcorcon, Madrid, Španjolska Ursapharm Arzneimittel GmbH, Saarbrücken, Njemačka |
| Marketing Authorisation Holder | McNeil Healthcare (Ireland) Limited, Tallaght, High Street, Office 5, 6 & 7, Block 5, Dublin, Irska |
| Marketing Authorisation Date | 02.05.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/436 |
| Registration Number | 381-12-01/14-24-44 |
| Prescription | bez recepta |
| Distribution | u ljekarni |
| Advertising to general public | dopušteno |
| ATC Code | R01AA07 |
| Medicinal product marketed in the Croatia | Privremeni prekid opskrbe |
| SmPC | download |
| PL | download |
